Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

NCT00210899 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

828

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Diseases, Infectious
Skin Diseases, Bacterial
Staphylococcal Skin Infections

Interventions

DRUG: ceftobiprole medocaril
DRUG: Vancomycin plus Ceftazidime

Sponsor

Basilea Pharmaceutica